Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Investigation of Combination Treatment With an Aromatase Inhibitor Exemestane and Carboplatin-Based Therapy for Postmenopausal Women With Advanced NSCLC.
Young PA, Márquez-Garbán DC, Noor ZS, Moatamed N, Elashoff D, Grogan T, Romero T, Sasano H, Saito R, Rausch R, Hamilton N, Dubinett SM, Garon EB, Pietras RJ. Young PA, et al. Among authors: garon eb. JTO Clin Res Rep. 2021 Feb 3;2(4):100150. doi: 10.1016/j.jtocrr.2021.100150. eCollection 2021 Apr. JTO Clin Res Rep. 2021. PMID: 34590007 Free PMC article.
Intracellular signaling molecules.
Garon EB, Dubinett SM. Garon EB, et al. J Thorac Oncol. 2009 Nov;4(11 Suppl 3):S1057-8. doi: 10.1097/01.JTO.0000361748.94541.7a. J Thorac Oncol. 2009. PMID: 19861915 Free article. No abstract available.
Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines.
Garon EB, Finn RS, Hosmer W, Dering J, Ginther C, Adhami S, Kamranpour N, Pitts S, Desai A, Elashoff D, French T, Smith P, Slamon DJ. Garon EB, et al. Mol Cancer Ther. 2010 Jul;9(7):1985-94. doi: 10.1158/1535-7163.MCT-10-0037. Epub 2010 Jun 29. Mol Cancer Ther. 2010. PMID: 20587667 Free PMC article.
Poly(ADP-ribose) polymerase inhibitors.
Garon EB, Dubinett SM. Garon EB, et al. J Thorac Oncol. 2010 Dec;5(12 Suppl 6):S455-6. doi: 10.1097/01.JTO.0000391363.10517.56. J Thorac Oncol. 2010. PMID: 21102236 Free article. No abstract available.
Novel drugs--miscellaneous category.
Hosmer WD, Dubinett SM, Garon EB. Hosmer WD, et al. Among authors: garon eb. J Thorac Oncol. 2010 Dec;5(12 Suppl 6):S468-9. doi: 10.1097/01.JTO.0000391369.48635.23. J Thorac Oncol. 2010. PMID: 21102242 Free article. No abstract available.
Mitotic inhibitors.
Garon EB, Dubinett SM. Garon EB, et al. J Thorac Oncol. 2011 Nov;6(11 Suppl 4):S1791-2. doi: 10.1097/01.JTO.0000407560.61287.3f. J Thorac Oncol. 2011. PMID: 22005532 Free PMC article. No abstract available.
Development of transcriptomic biomarker signature in human saliva to detect lung cancer.
Zhang L, Xiao H, Zhou H, Santiago S, Lee JM, Garon EB, Yang J, Brinkmann O, Yan X, Akin D, Chia D, Elashoff D, Park NH, Wong DTW. Zhang L, et al. Among authors: garon eb. Cell Mol Life Sci. 2012 Oct;69(19):3341-3350. doi: 10.1007/s00018-012-1027-0. Epub 2012 Jun 12. Cell Mol Life Sci. 2012. PMID: 22689099 Free PMC article.
The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth.
Garon EB, Finn RS, Hamidi H, Dering J, Pitts S, Kamranpour N, Desai AJ, Hosmer W, Ide S, Avsar E, Jensen MR, Quadt C, Liu M, Dubinett SM, Slamon DJ. Garon EB, et al. Mol Cancer Ther. 2013 Jun;12(6):890-900. doi: 10.1158/1535-7163.MCT-12-0998. Epub 2013 Mar 14. Mol Cancer Ther. 2013. PMID: 23493311 Free PMC article.
197 results